These reports do not prove causation, but they may help identify GLP-1 side effects that are underrepresented in clinical trials
doi: 10.4161/auto.7.7.15371 14 Feng Ju PanW
A randomized crossover trial in patients with cirrhosis and chronic encephalopathy further demonstrated that a predominantly vegetableprotein diet improved nitrogen balance, lowered ammonia and related metabolic markers, and modestly improved encephalopathy compared with an isocaloric, isonitrogenous animalprotein diet [121]
4 Conclusion and perspectives Application of antioxidants, pharmacologic activators of endogenous antioxidant systems, selective serotonin reuptake inhibitors, and MAO inhibitors may serve to decrease the deleterious effects of ROS in the pathogenesis of PTSD
Throughout your journey on GLP-1s, its important to be in touch with your doctor
A newer GLP-1 receptor agonist, tirzepatide, demonstrates weight loss as high as 20% change in body weight compared with 3% in the placebo group in a RCT
